After the FDA declined to approve Lykos Therapeutics’ MDMA-assisted therapy for post-traumatic stress disorder, companies are pivoting away from or delaying similar therapeutics targeting the ...
Stockhead on MSN24m
‘Closer to US commercialisation’ – EBR achieves major FDA milestoneEBR Systems has announced the US Food and Drug Administration (FDA) has accepted its final premarket approval (PMA) ...
Healthcare Asia on MSN42m
India-based drugmakers urged to improve standards amidst quality scrutinyThis follows cases of drug toxicity, resulting in fatalities in Central Asia, North America, and Africa. India’s ...
Lupin share price fell after the United States Food and Drug Administration (USFDA) issued 3 observations for its Pithampur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback